S&P・Nasdaq 本質的価値 お問い合わせ

GeneDx Holdings Corp. WGS NASDAQ

NASDAQ Global Market • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
64/100
4/7 Pass
SharesGrow Intrinsic Value
$974.26
+1344.2%
Analyst Price Target
$157.50
+133.5%

GeneDx Holdings Corp. (WGS) は上場企業です ヘルスケア セクターの Medical - Healthcare Information Services 業界で事業展開. 本社所在地は Stamford, CT, アメリカ. 現CEOは Katherine A. Stueland.

WGS を有する IPO日 2020-11-04, 1,000 名の正社員, に上場 NASDAQ Global Market, 時価総額 $1.98B.

GeneDx Holdings Corp. について

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

📍 North Tower, Stamford, CT 06902 📞 800 298 6470
会社詳細
セクターヘルスケア
業種Medical - Healthcare Information Services
アメリカ
取引所NASDAQ Global Market
通貨USD
IPO日2020-11-04
CEOKatherine A. Stueland
従業員数1,000
取引情報
現在価格$67.46
時価総額$1.98B
52週レンジ55.17-170.87
ベータ2.19
ETFいいえ
ADRいいえ
CUSIP81663L200
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る